31954-27-5

Basic information

• Product Name: BOC-GLY-OME
• Synonyms: N-[(1,1-Dimethylethoxy)carbonyl]glycine Methyl Ester;N-(tert-Butoxycarbonyl)glycine Methyl ester, 97%+;N-(tert-Butoxycarbonyl)glycine methyl ester 97%;N-(tert-Butoxycarbonyl)glycine Methyl Ester;Boc-glycine methyl ester≥ 98% (GC);N-BOC-Glycine methyleester;METHYL 2-[(TERT-BUTOXYCARBONYL)AMINO]ACETATE;BOC-GLY-OME
• CAS NO: 31954-27-5
• Molecular Formula: C₈H₁₅NO₄
• Molecular Weight: 189.21
• Product Categories: Amino Acid Derivatives;Glycine;Peptide Synthesis;Miscellaneous
• Mol File: 31954-27-5.mol
• Article Data: 61

Chemical Properties

• Boiling Point: 190 °C(lit.)
• Flash Point: 109 °C
• Appearance: /
• Density: 1.28 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00845mmHg at 25°C
• Refractive Index: n20/D 1.437(lit.)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: Chloroform, Ethyl Acetate
• PKA: 11.06±0.46(Predicted)
• CAS DataBase Reference: BOC-GLY-OME(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-GLY-OME(31954-27-5)
• EPA Substance Registry System: BOC-GLY-OME(31954-27-5)

Safety Data

• Safety Statements: 24/25
• WGK Germany: 3
• Hazardous Substances Data: 31954-27-5(Hazardous Substances Data)

Usage

Chemical Properties

Colorless to yellow liquid

Uses

Different sources of media describe the Uses of 31954-27-5 differently. You can refer to the following data:
1. Boc-glycine methyl ester is a amino acid glycine (G615990) derivative, used widely in various synthetic preparations of pharmaceutical goods and antioxidants. N-[(1,1-Dime thylethoxy)carbonyl]glycine Methyl Ester can be used in the preparation of Pregabalin (P704800), a GABA analogue used as an anticonvulsant.
2. It is used as a pharmaceutical, chemical, paint and dye intermediate.

InChI:InChI=1/C8H15NO4/c1-8(2,3)13-7(11)9-5-6(10)12-4/h5H2,1-4H3,(H,9,11)

Upstream product

• 4530-20-5 BOC-glycine 
• 616-38-6 carbonic acid dimethyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 883886-67-7 amino-acetic acid methyl ester hydrochloride salt 
• 5680-79-5 glycine ethyl ester hydrochloride 
• 4248-19-5 tert-butyl carbazate 
• 1415303-95-5 C₁₈H₂₉NO₂Si 
• 100038-76-4 methyl 2-(tert-butoxycarbonylamino)-3-pentenoate 
• 1291065-78-5 tert-butyl {2,3-dimethyl-1-(phenylsulfonyl)but-2-en-1-yl}carbamate 
• 77-76-9 2,2-dimethoxy-propane 
• 61985-23-7 methyl 1-imidazolecarboxylate 
• 67-56-1 methanol 
• 56-40-6 glycine 
• 298-12-4 Glyoxilic acid 

Downstream Products

• 65882-18-0 N-Glycyl-N'-acetylhydrazin 
• 42492-57-9 methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate 
• 61172-71-2 2-(tert-butoxycarbonylamino)-3-methoxy-3-oxopropanoic acid 
• 112392-58-2 dimethyl 2-oxo-3-(N-tert-butoxycarbonylamino)propane phosphonate 
• 26690-80-2 2-(N-tert-butoxycarbonylamino)ethanol 
• 89711-08-0 N-(t-butoxycarbonyl)glycinal 
• 5680-79-5 glycine ethyl ester hydrochloride 
• 138219-39-3 2-bromo-2-(N-tert-butoxycarbonylamino)acetic acid methyl ester 
• 6926-09-6 (tert-butoxycarbonyl)glycine hydrazide 
• 133457-73-5 ethyl <3--2-oxopropyl>n-butylphosphinate 
• 133457-89-3 ethyl <3--2-oxopropyl>(cyclopropylmethyl)phosphinate 
• 133457-84-8 ethyl <3--2-oxopropyl>(cyclohexylmethyl)phosphinate 
• 210690-46-3 3-(4-Acetylamino-phenyl)-2-tert-butoxycarbonylamino-3-hydroxy-propionic acid methyl ester 
• 223906-31-8 tert-butyl (2-hydroxy-2,2-diphenylethyl)carbamate 

Relevant articles and documents

Substituted aza five-membered ring derivative and application thereof in medicine

The invention discloses a substituted aza-five-membered ring derivative and application thereof to medicines. , The invention provides a substituted aza five-membered ring compound or a stereoisomer, a tautomer, an oxynitride, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and a pharmaceutical composition containing the compound of the present invention. The invention also discloses application of the compound or the pharmaceutical composition of the compound in preparation of a medicament for treating PDE4 related diseases such as atopic dermatitis (AD) or chronic obstructive pulmonary disease (COPD).

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.